Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Alternate Health Club vs Primary Clinic (Direct GLP)

Alternate Health Club
Graded #111

Higher grade

vs+4.299999999999997
Primary Clinic (Direct GLP)
Graded #219

Lower grade

The verdict

Alternate Health Club takes it — 69.8/100 to 65.5/100.

Alternate Health Club grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Alternate Health Club (alternatehealthclub.com) is a LegitScript-verified compounded GLP-1 telehealth platform offering compounded semaglutide at $129/month and compounded tirzepatide at $169/month.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAlternate Health Club +19
84
65
Dose & formulationAlternate Health Club +10
64
54
Clinical oversightAlternate Health Club +2
77
75
Labs & monitoringPrimary Clinic (Direct GLP) +24
52
76
FulfillmentPrimary Clinic (Direct GLP) +3
70
73
Contract termsAlternate Health Club +14
55
41
Alternate Health Club · left barPrimary Clinic (Direct GLP) · right bar

The numbers

MetricAlternate Health ClubPrimary Clinic (Direct GLP)
WeighScore69.8/10065.5/100
GradeCC
Scorecard rank#111#219
Semaglutide$129/mo (compounded)$85/mo (0.25-0.75 mg band, membership required, compounded)
Tirzepatide$169/mo (compounded)$133/mo (1.25-2.5 mg band, membership required, compounded)
CoverageCoverage not published10 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Alternate Health Club

Graded #111 · C

Strengths

  • $129/month compounded semaglutide is among the cheapest in the US market
  • $169/month compounded tirzepatide is competitive with established platforms
  • Complimentary workout and dietary plans bundled with medication — most peers don't
  • LegitScript verified
  • US-licensed clinicians

Where it loses points

  • Parent company / legal entity not publicly disclosed
  • State of incorporation not disclosed
  • Per-state availability not listed — confirm your state ships before committing
  • Pharmacy partners not publicly named
  • Unclear whether lab work is included

Strengths

  • Direct Primary Care model integrates GLP-1 with continuous primary care — unlike most direct-to-consumer platforms
  • GLP-1 at wholesale cost with no markup — semaglutide from $65/mo, tirzepatide from $110/mo (members only)
  • Unlimited primary care visits, direct text access, and same-day care bundled in the $89/mo membership
  • Routine labs and thousands of medications included in membership — no surprise bills
  • Per-dose pricing shown publicly for all 8 dose tiers of both semaglutide and tirzepatide

Where it loses points

  • The medication price is on top of an $89/mo direct-primary-care membership, which the FAQ states does not include the drug — all-in is about $174/mo for semaglutide and $222/mo for tirzepatide
  • Prices are published as dose BANDS rather than per dose, and the cheapest tirzepatide band starts at 1.25 mg, below the 2.5 mg labelled starting dose
  • The pricing is rendered entirely in JavaScript, so nothing on the page is readable without running the site's bundle
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard